Cargando…
Pharmacist responsiveness and readiness for oral antivirals for COVID-19: A rebuttal to the AMA statement regarding the Biden administration’s test-to-treat plan
On March 4, 2022, the American Medical Association (AMA) released a statement in response to the Biden administration’s plan of a test-to-treat plan allowing pharmacists to serve as locations to test and provide prescriptions for oral antiviral therapies for the treatment of coronavirus disease 2019...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Pharmacists Association®. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971105/ https://www.ncbi.nlm.nih.gov/pubmed/35450832 http://dx.doi.org/10.1016/j.japh.2022.03.023 |